2H-Pyran-2-one, 5,6-dihydro-4-methyl-6-[(1E,3E)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-butadien-1-yl]-

2H-Pyran-2-one, 5,6-dihydro-4-methyl-6-[(1E,3E)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-butadien-1-yl]- Basic information
Product Name:2H-Pyran-2-one, 5,6-dihydro-4-methyl-6-[(1E,3E)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-butadien-1-yl]-
Synonyms:2H-Pyran-2-one, 5,6-dihydro-4-methyl-6-[(1E,3E)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-butadien-1-yl]-
CAS:43059-50-3
MF:C20H28O2
MW:300.44
EINECS:
Product Categories:
Mol File:43059-50-3.mol
2H-Pyran-2-one, 5,6-dihydro-4-methyl-6-[(1E,3E)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-butadien-1-yl]- Structure
2H-Pyran-2-one, 5,6-dihydro-4-methyl-6-[(1E,3E)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-butadien-1-yl]- Chemical Properties
Safety Information
MSDS Information
2H-Pyran-2-one, 5,6-dihydro-4-methyl-6-[(1E,3E)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-butadien-1-yl]- Usage And Synthesis
Uses11,12-Dihydro-11-hydroxyretinoic Acid δ-Lactone is an intermediate used in the synthesis of 4-Keto 13-cis-Retinoic acid-d3 (K204972), which is labeled metabolite of Retinoic Acid in neuroblastoma.
2H-Pyran-2-one, 5,6-dihydro-4-methyl-6-[(1E,3E)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-butadien-1-yl]- Preparation Products And Raw materials
Tag:2H-Pyran-2-one, 5,6-dihydro-4-methyl-6-[(1E,3E)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-butadien-1-yl]-(43059-50-3) Related Product Information